Dignitana Announces Decision by Medicare to Reassign Payment for Scalp Cooling
New classification enables reimbursement to cancer centers providing DigniCap to chemotherapy patientsDignitana , world leader in scalp cooling innovation, announces that the U.S. Centers for Medicare & Medicaid Services (CMS) has reassigned payment for scalp cooling for Medicare claims filed using CPT code 0662T. This treatment has been reassigned to New Technology APC 1520 with a National Average Payment of $1,850.50, effective January 1, 2022. "This decision ensures that thousands of cancer patients will now have access to life-changing scalp cooling therapy